Valuation Iqvia Holdings Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 15:29:15 20/05/2026 BST			5-day change	1st Jan Change
167.02 ^USD	-3.55%		-3.95%	-26.55%

03:14pm	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE
05-13	IQVIA And Kexing Biopharm Expand Strategic Collaboration To Accelerate Global Biosimilar Development Using AI-Enabled Capabilities	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	53,900	38,056	42,227	35,667	38,387	28,904	-	-
Change	-	-29.39%	10.96%	-15.54%	7.63%	-24.7%	-	-
Enterprise Value (EV) ¹	64,659	49,587	54,524	47,948	52,131	42,820	41,711	40,299
Change	-	-23.31%	9.96%	-12.06%	8.73%	-17.86%	-2.59%	-3.39%
P/E ratio	57x	35.8x	31.7x	26.2x	28.8x	21.1x	17.5x	14.8x
PBR	9.11x	6.6x	7.05x	5.94x	5.96x	3.99x	3.44x	2.98x
PEG	-	2.3x	1.2x	9.55x	6.16x	4.43x	0.9x	0.8x
Capitalization / Revenue	3.88x	2.64x	2.82x	2.32x	2.35x	1.67x	1.58x	1.49x
EV / Revenue	4.66x	3.44x	3.64x	3.11x	3.2x	2.48x	2.28x	2.08x
EV / EBITDA	21.4x	14.8x	15.3x	13x	13.8x	10.7x	9.78x	8.87x
EV / EBIT	25x	17.8x	17.9x	15.5x	23.9x	16.4x	14.2x	12.1x
EV / FCF	28.1x	31.3x	36.3x	22.7x	25.4x	19.9x	17.8x	15.7x
FCF Yield	3.56%	3.2%	2.75%	4.41%	3.93%	5.03%	5.61%	6.38%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	4.95	5.72	7.29	7.49	7.84	8.214	9.87	11.73
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	13,874	14,410	14,984	15,405	16,310	17,282	18,290	19,373
EBITDA ¹	3,022	3,346	3,569	3,684	3,788	3,999	4,265	4,545
EBIT ¹	2,591	2,779	3,050	3,100	2,182	2,616	2,939	3,326
Net income ¹	966	1,091	1,358	1,373	1,360	1,387	1,626	1,883
Net Debt ¹	10,759	11,531	12,297	12,281	13,744	13,916	12,808	11,396
Reference price ²	282.14	204.89	231.38	196.51	225.41	173.18	173.18	173.18
Nbr of stocks (in thousands)	191,040	185,740	182,500	181,500	170,300	166,900	-	-
Announcement Date	15/02/22	10/02/23	14/02/24	06/02/25	05/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IQVIA HOLDINGS INC.	21.08x	2.48x	10.71x	-.--%	28.9B
LONZA GROUP AG	29.51x	5.23x	16.21x	1.12%	43.14B
BEONE MEDICINES AG	45x	4.51x	28.77x	-.--%	33.02B
REVOLUTION MEDICINES, INC.	-18.56x	281.56x	-16.75x	-.--%	31.32B
CELLTRION, INC.	29.22x	7.55x	19.41x	0.42%	25.34B
EUROFINS SCIENTIFIC SE	21.31x	1.87x	8.24x	1.25%	12.5B
MEDPACE HOLDINGS, INC.	24.65x	3.91x	17.8x	-.--%	11.99B
IONIS PHARMACEUTICALS, INC.	-20.71x	13.46x	-20.39x	-.--%	12.2B
Average	16.44x	40.07x	8.00x	0.35%	24.8B
Weighted average by Cap.	19.34x	48.83x	10.05x	0.38%